+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

UK Inhaler Market 2019-2025

  • ID: 4987974
  • Report
  • January 2020
  • Region: United Kingdom
  • Orion Market Research Private Limited

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 3M Co.
  • Adherium Ltd.
  • Bespak
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pulmatrix Inc.
  • MORE
UK Inhaler Market Size, Share & Trends Analysis Report by Device (Metered Dose Inhaler, Dry Powdered Inhaler, and Nebulizer), by Type (Preventive Inhaler, Reliever Inhaler, and Long Acting Bronchodilators Inhaler), by Application (Asthma and Chronic Obstructive Pulmonary Disease (COPD)), by End-User (Homecare and Hospitals and Clinics) and Forecast 2019-2025.

UK inhaler market was valued at around $1.5 billion in 2018 and is anticipated to grow at a substantial rate of 1.0% during the forecast period. Inhalers are used for providing medication to the patients through lungs. These are used for treatment of patient from asthma attacks and other respiratory ailments. As the prevalence of asthma and other diseases increases across UK, the demand of inhalers is also expected to increase for treatment purposes. As per International Monetary Fund GDP of the country was $2.9 trillion in 2017. UK comprises of England, Scotland, Wales and Northern Ireland. Total population of the country in 2017 was 65 million, out of which about 18% are of geriatric population. Mortalities related to asthma and COPD are high in UK and due to these a significant investment by government and people can be forecast in the near future.

The UK inhaler market is segmented on the basis of device, type, application, and end-user. On the basis of device, the market is sub-segmented into metered dosed inhaler, dry powdered inhaler, and nebulizer. The dry powder inhaler is estimated to have largest market share in the UK inhaler market due to providing easy inhalation solution. Whereas, the market for metered dose inhaler is estimated to be the fastest growing at a CAGR during the forecast period owing to innovations and collaborations by the companies for the development of metered dosed inhaler. Based on the type, preventive, reliever, and long acting bronchodilators inhaler are analyzed. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing inhaler to cater to a wide range of customers within the region and across the globe. The major players of the UK inhaler market include Boehringer Ingelheim International GmbH, AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, Teva Pharmaceuticals Industries Ltd., Koninklijke Philips N.V., and Bespak. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players.

Research Methodology

The market study of the UK inhaler market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report is intended for inhaler manufacturers, contract research organizations (CROs), healthcare sector, market research firms, and government organizations, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. UK Inhaler Market Research and Analysis by Device

2. UK Inhaler Market Research and Analysis by Type

3. UK Inhaler Market Research and Analysis by Application

4. UK Inhaler Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the UK inhaler market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the UK inhaler market.
  • Insights about market determinants which are stimulating the UK inhaler market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Co.
  • Adherium Ltd.
  • Bespak
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pulmatrix Inc.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. UK Inhaler Market by Device
5.1.1. Metered Dose Inhaler
5.1.2. Dry Powder Inhaler
5.1.3. Nebulizer
5.2. UK Inhaler Market by Type
5.2.1. Preventive Inhaler
5.2.2. Reliever Inhaler
5.2.3. Long Acting Bronchodilators Inhaler
5.3. UK Inhaler Market by Application
5.3.1. Asthma
5.3.2. Chronic Obstructive Pulmonary Disease (COPD)
5.4. UK Inhaler Market by End-User
5.4.1. Homecare
5.4.2. Hospitals and Clinics

6. Company Profiles
6.1. 3M Co.
6.2. Acorda Therapeutics, Inc.
6.3. Adamis Pharmaceuticals Corp.
6.4. Adherium Ltd.
6.5. AstraZeneca PLC
6.6. Bespak
6.7. Boehringer Ingelheim International GmbH
6.8. Chiesi Farmaceutici S.P.A.
6.9. GF Health
6.10. GlaxoSmithKline PLC
6.11. H&T Presspart Manufacturing Ltd.
6.12. Koninklijke Philips N.V.
6.13. Novartis AG
6.14. Omron Healthcare Inc.
6.15. ResMed Corp.
6.16. Pulmatrix Inc.
6.17. Savara, Inc.
6.18. Teicos Pharma Ltd.
6.19. Teva Pharmaceuticals Industries Ltd.
6.20. Vitalograph Ltd.
Note: Product cover images may vary from those shown
  • 3M Co.
  • Acorda Therapeutics, Inc.
  • Adamis Pharmaceuticals Corp.
  • Adherium Ltd.
  • AstraZeneca PLC
  • Bespak
  • Boehringer Ingelheim International GmbH
  • Chiesi Farmaceutici S.P.A.
  • GF Health
  • GlaxoSmithKline PLC
  • H&T Presspart Manufacturing Ltd.
  • Koninklijke Philips N.V.
  • Novartis AG
  • Omron Healthcare Inc.
  • ResMed Corp.
  • Pulmatrix Inc.
  • Savara, Inc.
  • Teicos Pharma Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Vitalograph Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll